Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Achyut HealthcareBOM:543499 +4.11%78 PS Ratio is 28.06 as of Aug. 09, 2026, which is 67% below its 10-year median of 84.87. GuruFocus rates BOM:543499 with a GF Score™ of 78/100 and a GF Value™ of ₹9.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Achyut Healthcare ranks worse than 96.8% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Achyut Healthcare's share price is ₹7.10.
Achyut Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.25. Hence, Achyut Healthcare's PS Ratio for today is 28.06.
Good Sign:
Achyut Healthcare Ltd stock PS Ratio (=14.43) is close to 2-year low of 14.43.
The historical rank and industry rank for Achyut Healthcare's PS Ratio or its related term are showing as below:
BOM:543499'
s PS Ratio Range Over the Past 10 Years
Min: 19.49 Med: 84.87 Max: 161.28
Current: 28.06
During the past 8 years, Achyut Healthcare's highest PS Ratio was 161.28. The lowest was 19.49. And the median was 84.87.
BOM:543499's PS Ratio is ranked worse than 96.8% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.53
vs BOM:543499: 28.06
During the past 12 months, the average Revenue per Share Growth Rate of Achyut Healthcare was 281.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 33.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 31.30% per year.
During the past 8 years, Achyut Healthcare's highest 3-Year average Revenue per Share Growth Rate was 418.00% per year. The lowest was -64.40% per year. And the median was 104.70% per year.
Achyut Healthcare (BOM:543499) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Achyut Healthcare PS Ratio Related Terms
Achyut Healthcare PS Ratio Historical Data
* Premium members only.
The historical data trend for Achyut Healthcare's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Achyut Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Achyut Healthcare PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Achyut Healthcare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Achyut Healthcare's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Achyut Healthcare's Share Price of today is ₹7.10. Achyut Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Achyut Healthcare (BOM:543499) has a PS Ratio of 28.06 as of Aug. 09, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Achyut Healthcare and its competitors. This is 67% below median its historical median of 84.87. Over the past decade, Achyut Healthcare's PS Ratio has ranged from 19.49 to 161.28. According to the industry distribution chart, Achyut Healthcare ranks #636 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 96.8%.
Is Achyut Healthcare's PS Ratio too high?
Achyut Healthcare's current PS Ratio of 28.06 is 67% below median its 10-year median of 84.87. Over the past 10 years, this metric has ranged from a low of 19.49 to a high of 161.28. The Healthcare Providers & Services industry median PS Ratio is 1.53. Achyut Healthcare's value of 28.06 is 1734% above this industry median. Based on the distribution chart, Achyut Healthcare ranks #636 out of 657 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Achyut Healthcare has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Achyut Healthcare's PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Achyut Healthcare ranks #636 out of 657 companies for PS Ratio. This places Achyut Healthcare in the lower half of its industry. The industry median PS Ratio is 1.53. Achyut Healthcare's value of 28.06 is 1734% above this benchmark. Historically, Achyut Healthcare's own PS Ratio has ranged from 19.49 to 161.28 over the past decade. While the company's 10-year median is 84.87 vs. the industry median of 1.53, Achyut Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.53, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Achyut Healthcare's current PS Ratio of 28.06 is 1734% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Achyut Healthcare and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Achyut Healthcare's current PS Ratio is 28.06, which is 67% below median its own 10-year median of 84.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Achyut Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Achyut Healthcare (BOM:543499) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹9.55, compared to a current price of ₹7.10 — trading 25.7% below its estimated fair value. The current PS Ratio is 28.06, which is 67% below median its 10-year median of 84.87 and 1734% above the Healthcare Providers & Services industry median of 1.53. Achyut Healthcare's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Achyut Healthcare (BOM:543499), the current PS Ratio is 28.06 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Achyut Healthcare (BOM:543499) Overvalued in 2026?
Based on GuruFocus' analysis, Achyut Healthcare stock appears to be undervalued.
The current stock price of ₹7.10 is trading 25.7% below its estimated GF Value™ of ₹9.55.
GuruFocus considers Achyut Healthcare to be Modestly Undervalued.
Key valuation signals for BOM:543499:
PS Ratio: 28.06 (67% below median its 10-year median of 84.87)
GF Value™: ₹9.55 vs. price of ₹7.10 (25.7% below fair value)
Industry Position: 1734% above the Healthcare Providers & Services median (#636 of 657)
No single metric tells the full story. See the BOM:543499 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Achyut Healthcare Ltd is engaged in the manufacturing and trading of Pharmaceutical formulations in the forms of Tablets, Capsules, Oral liquids, and Injectables. The company has business operations in both domestic and international markets. It generates the majority of its revenue from domestic markets.
78GF Score
Get the complete analysis for BOM:543499
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543499 has been successfully added to your 
